GUTS
Fractyl Health, Inc. Common Stock
NASDAQ: GUTS · HEALTHCARE · BIOTECHNOLOGY
$0.64
+5.90% today
Updated 2026-04-30
Market cap
$103.61M
P/E ratio
—
P/S ratio
7,575.74x
EPS (TTM)
$-1.86
Dividend yield
—
52W range
$0 – $3
Volume
2.3M
Fractyl Health, Inc. Common Stock (GUTS) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-744.00%
ROA
-52.70%
Debt/equity
-19.57x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | — | $-30.59M | — | — | — |
| 2020 | $0.00 | $-30.48M | — | — | — |
| 2021 | $0.00 | $-38.73M | — | — | — |
| 2022 | $0.00 | $-46.45M | — | — | — |
| 2023 | $120000.00 | $-77.09M | 35.83% | -42,363.33% | -64,242.50% |
| 2024 | $93000.00 | $-68.69M | 46.24% | -100,570.97% | -73,864.52% |
| 2025 | $0.00 | $-140.95M | — | — | — |